摘要
细胞色素氧化酶P450(CYP450)作为重要的药物Ⅰ相代谢酶,广泛参与药物在人体内羟化、氧化、还原、水解等多种Ⅰ相反应。CYP4503A(CYP3A)是CYP450家族中的重要成员,
出处
《蚌埠医学院学报》
CAS
2011年第2期201-204,共4页
Journal of Bengbu Medical College
参考文献26
-
1Gibson GG,Plant NJ,Swales KE,et al.Receptor-dependent transcriptional activation of cytochrome P4503A genes:induction mechanisms,species differences and interindividual variation in man[J].Xenobiotica,2002,32(3):165-206.
-
2Lamba JK,Lin YS,Schuetz EG,et al.Genetic contribution to variable human CYP3A-mediated metabolism[J].Adv Drug Deliv Rev,2002,54(10):1274-1294.
-
3Nicola FS,William DF,Alex S,et al.Recent advances in pharmacogenetic approaches to anticancer drug development[J].Drug Dev Res,2004,62(3):233-253.
-
4Chen CS,Jounaidi Y,Waxman DJ,et al.Enantioselective metabolism and cytotoxicity of R-IFOSFAMIDE and S-IFOSFAMIDE by tumor cell-expressed cytochromes P450[J].Drug Detab Dispos,2005,33(9):1261-1267.
-
5Pakakasama S,Mukda E,Sasanakul W,et al.Polymorphisms of drug metabolizing enzymes and risk of childhood acute lymphoblastic leukemia[J].Am J Hematol,2005,79(3):202-205.
-
6黄珍,柴忆欢,岑建农,何海龙,李捷,卢俊.CYP3A5基因多态性与儿童急性白血病的相关性研究[J].中华儿科杂志,2007,45(7):546-548. 被引量:5
-
7Felix CA,Walker AH,Lange BJ,et al.Association of CYP3A4 genotype with treatment-related leukemia[J].Proc Natl Acad Sci U S A,1998,95(22):13176-13181.
-
8Lopes LF,Piccoli Fde S,Paixao VA,et al.Association of CYP3A4 genotype with detection of Vγ/Jβ trans-rearrangements in the peripheral blood leukocytes of pediatric cancer patents undergoing chemotherapy for ALL[J].Leuk Res,2004,28(4):1281-1286.
-
9Leskela S,Honrado E,Montero-Conde C,et al.Cytochrome P450 3A5 is highly expressed in normal prostate cells but absent in prostate cancer[J].Endocr Relat Cancer,2007,14(3):645-654.
-
10Stone A,Ratnasinghe LD,Emerson GL,et al.CYP3A43 Pro(340)Ala polymorphism and prostate cancer risk in African Americans and Caucasians[J].Cancer Epidemiol Biomarkers Prev,2005,14(5):1257-1261.
二级参考文献8
-
1Felix CA, Wakler AH, Langer BJ, et al. Association of CYP3A4 genotype with treatment-related leukemia. Proc Natl Acad SCI USA,1998, 95:13176-13181.
-
2van Schaik RH, van der Heiden IP, wan den Anker JN,et al. CYP3A5 variant allele frequencies in Dutch Caucasians. Clin C hem, 2002,48 : 1668 -1671.
-
3Rothman N, Wacholder S, Caporaso NE, et al. The use of common genetic polymorphisms to enhance the epidemiologic study of environmental carcinogens. Biochim Biophys Acta,2001,1471 : C1-C10.
-
4Jatinder KL,Yvonne SL, Thummel KE, et al. Genetic contribution to variable human CYP3A-mediated metabolism. Advanced drug delivery reviews, 2002,54 : 1271-1294.
-
5Wojnowski L. Genetics of the variable expression of CYP3A in humans. Ther Drug Monit, 2004,26 : 192-199.
-
6Kuehl P, Chang J, Lin Y, et al. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat Genet ,2001,27 : 383-391.
-
7Pakakasama S, Mukda E, Sasanakui W, et al. Polymorphisms of drug metabolizing enzymes and risk of acute lymphoblastic leukemia. Am J Hematol,2005 ,79 :202-205.
-
8Goh BC, Lee SC, Wang Lz, et al. Explaining interindividual variability of docetaxel pharmacokinetics and pharmacodynamics in Asians through phenotyping and genotyping strategies. J Clin Oncol, 2002,20 : 3683 -3690.
共引文献4
-
1黄珍,柴忆欢,岑建农,何海龙,李捷.CYP3A5基因在急性白血病儿童中的表达及临床意义[J].中国当代儿科杂志,2009,11(7):549-554. 被引量:3
-
2黄菲,夏春华,熊玉卿.细胞色素P450(CYP)3A5与CYP2C19基因多态性对伏立康唑在健康人体的药代动力学特征的影响[J].中国临床药理学杂志,2011,27(10):762-766. 被引量:7
-
3黄珍,陈敏,曾炜炜,李原.温州地区急性白血病儿童CYP3A5基因多态性研究[J].温州医学院学报,2014,44(10):733-736.
-
4黄珍,童洪飞,陈敏,曾炜炜,李原.急性淋巴细胞白血病患儿CYP3A5基因多态性对柔红霉素代谢和不良反应的研究[J].中国临床药理学杂志,2015,31(6):443-446. 被引量:1
同被引文献13
-
1李爽,胡卓汉,缪晓辉.慢性乙型肝炎病毒感染对人肝细胞色素酶 P450 3A4的影响[J].中华医学杂志,2006,86(38):2703-2706. 被引量:5
-
2潘伟,张磊,习志刚,杨红.细胞色素氧化酶CYP2C9基因多态性与药物代谢[J].广州医学院学报,2007,35(1):63-66. 被引量:9
-
3李智,王果,周宏灏.CYP2C9基因多态性及其功能意义研究进展[J].中国临床药理学与治疗学,2008,13(6):601-609. 被引量:22
-
4王宪刚,苗佳.CYP3A5基因遗传多态性及临床研究进展[J].华西医学,2010,25(10):1930-1933. 被引量:3
-
5黄洁琼.CYP2C8代谢紫杉醇产物6α-羟基紫杉醇的LC-MS/MS检测[J].科技视界,2016(8):230-230. 被引量:1
-
6周君,陈菊.CYP3A5基因多态性与终末期肾脏疾病患者使用钙拮抗剂降压疗效的关系[J].临床肾脏病杂志,2016,16(2):81-86. 被引量:6
-
7龚由之,江应安.肝癌发生、发展过程中部分基因表达异常对其诊断及治疗的意义[J].胃肠病学和肝病学杂志,2016,25(8):848-851. 被引量:5
-
8许菊青,蒋峰.CYP3A4、CYP3A5多态性与肿瘤的关系[J].实用老年医学,2017,31(1):79-82. 被引量:1
-
9董志珍,朱小东,李照,毛雨鸽,柴跃龙,姚登福,孙惠川,朱继业,马宽生.2016年肝癌基础与临床研究进展[J].中华肝脏病杂志,2017,25(2):85-93. 被引量:37
-
10白文萱,高健,钱程,张献全.肝癌相关差异表达基因的生物信息学分析[J].中华肝脏病杂志,2017,25(6):435-439. 被引量:7
-
1黄珍,柴忆欢.CYP3A基因与肿瘤易感性及其治疗研究进展[J].国际儿科学杂志,2007,34(5):367-370.
-
2张荣,朱大岭.CYP3A基因表达分子机制的研究进展[J].医学研究通讯,2005,34(2):57-59. 被引量:5
-
3张万广,陈孝平,王其,严斌,张必翔,张志伟.肝癌细胞耐药诱导过程中过氧化物酶增殖物激活受体α的表达[J].华中科技大学学报(医学版),2006,35(5):588-590.
-
4赵明,林鹏,李丽,阮宏莹.外周血CYP3A和GSTM1基因多态性检测对头颈部NHL化疗效果预测意义的分析[J].中华肿瘤防治杂志,2012,19(24):1866-1869. 被引量:1
-
5毛雪,沈芸.CYP3A4与CYP3A5基因多态性与糖皮质激素类药物代谢的研究进展[J].中国老年保健医学,2016,14(1):74-77. 被引量:4
-
6王婷,陈芳源,黄洪晖,钟华,胡霄飞,欧阳仁荣.柔红霉素、地塞米松、全反式维甲酸对白血病细胞系CYP3 A5基因转录及活性的调控[J].上海医学,2004,27(12):923-926.
-
7朱冰,周宏灏.CYP3A的分子机制研究进展[J].中国药理学通报,2000,16(6):614-618. 被引量:8
-
8黄平,丁惠萍,任华益.细胞色素P4501B1基因多态性与乳腺癌易感性[J].中国肿瘤,2002,11(3):161-163. 被引量:1
-
9蒋欣,宋东奎,张莉蓉.细胞色素氧化酶P4504B1基因突变与膀胱癌遗传易感性的关系[J].郑州大学学报(医学版),2015,50(1):82-85.
-
10滕立臣,王长希,陈立中,李嘉丽,费继光,邓素雄,邱江,李军,陈国栋.受者CYP3A5基因多态性对肾移植术后早期血他克莫司浓度的影响[J].中华器官移植杂志,2009,30(5):261-263. 被引量:1